Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 6.

Montavon Sartorius, Céline; Mirza, Uzma; Schötzau, Andreas; Mackay, Gillian; Fink, Daniel; Hacker, Neville; Heinzelmann-Schwarz, Viola (2018). Impact of the new FIGO 2013 classification on prognosis of stage I epithelial ovarian cancers. Cancer Management and Research, 1:4709-4718.

Montavon Sartorius, Céline; Schoetzau, Andreas; Kettelhack, Henriette; Fink, Daniel; Hacker, Neville F; Fedier, André; Jacob, Francis; Heinzelmann-Schwarz, Viola (2018). ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer. PLoS ONE, 13(3):e0195213.

Anugraham, Merrina; Jacob, Francis; Everest-Dass, Arun V; Schoetzau, Andreas; Nixdorf, Sheri; Hacker, Neville F; Fink, Daniel; Heinzelmann-Schwarz, Viola; Packer, Nicolle H (2017). Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma. Molecular Oncology, 11(11):1595-1615.

Henry, Claire; Llamosas, Estelle; Knipprath-Meszaros, Alexandra; Schoetzau, Andreas; Obermann, Ellen; Fuenfschilling, Maya; Caduff, Rosemarie; Fink, Daniel; Hacker, Neville; Ward, Robyn; Heinzelmann-Schwarz, Viola; Ford, Caroline (2015). Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion. OncoTarget, 6(37):40310-40326.

Heinzelmann-Schwarz, Viola; Lorez, Matthias (2014). Trends in survival from cancer of the corpus uteri in Switzerland. Schweizer Krebsbulletin, 34(2):137-142.

Buehler, Michelle; Tse, Brian; Leboucq, Alix; Jacob, Francis; Caduff, Rosmarie; Fink, Daniel; Goldstein, Darlene R; Heinzelmann-Schwarz, Viola (2013). Meta-Analysis of microarray data identifies GAS6 expression as an independent predictor of poor survival in ovarian cancer. BioMed Research International, 2013:238284.

This list was generated on Sun Apr 21 18:29:06 2019 CEST.